Daiichi Life Insurance Co. Ltd. Takes Position in AMETEK, Inc. $AME

Daiichi Life Insurance Co. Ltd. bought a new stake in AMETEK, Inc. (NYSE:AMEFree Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 9,450 shares of the technology company’s stock, valued at approximately $2,286,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in AMETEK by 6.2% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 487,238 shares of the technology company’s stock worth $101,901,000 after purchasing an additional 28,621 shares during the period. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund bought a new stake in AMETEK in the fourth quarter valued at approximately $1,027,000. Fifth Third Bancorp raised its stake in AMETEK by 1,060.3% in the first quarter. Fifth Third Bancorp now owns 82,948 shares of the technology company’s stock valued at $17,781,000 after buying an additional 75,799 shares during the period. Wescott Financial Advisory Group LLC acquired a new stake in shares of AMETEK in the fourth quarter valued at approximately $1,122,000. Finally, Investment Management Corp VA ADV acquired a new stake in shares of AMETEK in the fourth quarter valued at approximately $496,000. 87.43% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at AMETEK

In other news, insider David F. Hermance sold 6,608 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $254.00, for a total value of $1,678,432.00. Following the completion of the sale, the insider owned 42,509 shares of the company’s stock, valued at approximately $10,797,286. The trade was a 13.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.54% of the company’s stock.

AMETEK Price Performance

AMETEK stock opened at $239.67 on Monday. The company has a market capitalization of $54.93 billion, a price-to-earnings ratio of 35.04, a PEG ratio of 3.06 and a beta of 0.98. The company has a current ratio of 1.21, a quick ratio of 0.76 and a debt-to-equity ratio of 0.09. AMETEK, Inc. has a 12 month low of $179.24 and a 12 month high of $261.16. The stock’s 50 day moving average is $240.90 and its 200-day moving average is $232.01.

AMETEK (NYSE:AMEGet Free Report) last released its quarterly earnings results on Tuesday, August 4th. The technology company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.10. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $1.95 billion. AMETEK had a return on equity of 16.93% and a net margin of 20.04%.The firm’s revenue for the quarter was up 15.0% compared to the same quarter last year. During the same period last year, the firm posted $1.78 EPS. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. Equities research analysts expect that AMETEK, Inc. will post 8.32 EPS for the current year.

AMETEK Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.6%. AMETEK’s dividend payout ratio (DPR) is currently 19.88%.

Analysts Set New Price Targets

A number of research firms recently weighed in on AME. Seaport Research Partners reissued a “buy” rating and set a $290.00 target price on shares of AMETEK in a report on Wednesday, August 5th. Citigroup raised their price target on AMETEK from $257.00 to $261.00 and gave the company a “neutral” rating in a report on Wednesday, August 5th. Royal Bank Of Canada lifted their price objective on shares of AMETEK from $260.00 to $291.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Rothschild & Co Redburn set a $265.00 price objective on shares of AMETEK in a report on Thursday, June 18th. Finally, Weiss Ratings raised shares of AMETEK from a “buy (b-)” rating to a “buy (b)” rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $266.80.

Check Out Our Latest Report on AME

AMETEK Profile

(Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

Featured Stories

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.